Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Lawrence Livermore National Laboratory
National Institutes of Health (NIH)
Information provided by (Responsible Party):
University of California, Davis
ClinicalTrials.gov Identifier:
NCT01261299
First received: December 9, 2010
Last updated: August 31, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: November 2016
  Estimated Primary Completion Date: November 2016 (Final data collection date for primary outcome measure)